The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.

This week, a phase 3 clinical trial showed aztreonam-avibactam might be treatment option for patients facing multidrug-resistant infections. Meanwhile, research shows that penicillin allergies in ...

Zithromax (azithromycin) is often the first-line treatment since it is effective against many different microbes that can ...

Purpose The pharmacology, safety, efficacy, pharmacokinetics, pharmacodynamics, current place in therapy, and potential future therapeutic uses of inhaled aztreonam are reviewed. Conclusion ...

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It purchased in 2006 Corus Pharma and its inhaled antibiotic, aztreonam lysine, for $365 million, and then Myogen for $2.5 billion, bringing aboard ambrisentan, an endothelin receptor antagonist ...

based on the results of the earlier TARGET study which showed non-inferiority for the drug compared to vancomycin plus aztreonam. If it gets a green light, it will be the first antibiotic in the ...

A Clinical and Laboratory Standards Institute-endorsed method (ie, broth disk elution method) to test for activity of the combination of ceftazidime-avibactam and aztreonam for MBL-producing ...

Find all the commercial and brand names of generic drug called Aztreonam. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

The CHMP also backed approval of Pfizer’s antibiotic infusion Emblaveo (aztreonam-avibactam) to treat complicated intra-abdominal infection (cIAI) and complicated urinary tract infection (cUTI ...

Amikacin VHA Plus 112180 1000 mg (100 mg/mL) in 0.45% sodium chloride injection SP 0.4 mL/min Aztreonam Bristol-Myers Squibb 9H28459 2 g (200 mg/mL) in 0.45% sodium chloride injection SP 0.4 mL ...

Pfizer Inc. (NYSE: PFE) will present data across its infectious disease portfolio at the upcoming IDWeek 2024 congress, held ...